Item 9.01 Financial Statements and Exhibits.

(a) Financial Statements of Businesses Acquired.

1. The financial statements of Pre-Clinical Research Services, Inc. as of and for


    the fiscal year ended December 31, 2018, together with the notes thereto and
    the report of independent registered public accounting firm thereon, are filed
    as Exhibit 99.1 to this Amendment No. 1 to Current Report on Form 8-K/A and
    are incorporated herein by reference.

2. The unaudited financial statements of Pre-Clinical Research Services, Inc. as


    of and for the nine months ended September 30, 2019, together with the notes
    thereto, are filed as Exhibit 99.2 to this Amendment No. 1 to Current Report
    on Form 8-K/A and are incorporated herein by reference.

(b) Pro Forma Financial Information.



  1. Unaudited pro forma condensed combined balance sheet as of September 30, 2019
     and unaudited statements of operations for the year ended September 30, 2019,
     each giving effect to the Acquisition and related financing, and the notes
     thereto, are filed as Exhibit 99.3 to this Amendment No. 1 to Current Report
     on Form 8-K/A and are incorporated herein by reference. They were prepared
     for informational and illustrative purposes in accordance with Rule 8-05 of
     Regulation S-X. Such information is preliminary and based on currently
     available information and assumptions that the Company believes are
     reasonable but may be subject to change. They shall not be deemed to be
     "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as
     amended (the "Exchange Act"), or otherwise subject to the liabilities of that
     section, nor shall such information be deemed incorporated by reference in
     any filing under the Securities Act of 1933, as amended, or the Exchange Act,
     except as set forth by specific reference in such filing.




(c)  None.



(d) Exhibits

The following exhibits are being filed as part of this report:





Exhibit No.                                Description
  23.1           Consent of Soukup, Bush & Associates P.C., independent registered
               public accounting firm to Pre-Clinical Research Services, Inc.

  99.1           Audited financial statements of Pre-Clinical Research Services,
               Inc. as of and for the fiscal year ended December 31, 2018,
               together with the notes thereto and the report of independent
               registered public accounting firm thereon.

  99.2           Reviewed financial statements of Pre-Clinical Research Services,
               Inc. as of and for the nine months ended September 30, 2019,
               together with the notes thereto and the report of independent
               registered public accounting firm thereon.

  99.3           Unaudited pro forma condensed consolidated balance sheet as of
               September 30, 2019 and unaudited condensed consolidated statements
               of operations and comprehensive income (loss) for the year ended
               September 30, 2019, each giving effect to the acquisition of
               Pre-Clinical Research Services, Inc. and related financing, and the
               notes thereto.

© Edgar Online, source Glimpses